On March 20, 2017 Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, reported that the company will present five scientific posters at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting in Phoenix, AZ (Press release, Myriad Genetics, MAR 20, 2017, View Source [SID1234518188]). The presentations will highlight new data on variant classification and hereditary cancer syndromes.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"As genetic testing for hereditary cancer syndromes increases, we are generating tremendous volumes of data and identifying new genetic variants every day. Our highest priority is making sure patients and their families get accurate test results, which demands years of variant classification experience," said Johnathan Lancaster, M.D., Ph.D., chief medical officer, Myriad Genetic Laboratories. "Myriad has been the leader in variant classification for more than 25 years, making us the most experienced commercial lab in the industry. Our passion for helping patients continues, and we are very excited to be presenting five new cutting-edge studies at ACMG that advance the science of variant classification."

The poster abstracts are now available here. Follow Myriad on Twitter via @MyriadGenetics to stay informed about news and updates from the Company.

Featured Poster Presentations

Title: A significant proportion of TP53 pathogenic variants detected with a hereditary pan-cancer NGS panel are somatically acquired.
Date: Thursday, March 23, 2017: 10:00—11:30 a.m. MST.
Location: Poster 173.
Presenter: Bradford Coffee.

Title: Complexities in hereditary cancer variant classification: Three case examples.
Date: Friday, March 24, 2017: 10:30 a.m.—12:00 p.m. MST.
Location: Poster 154.
Presenter: Erin Mundt.

Title: Case report: Sub-clinical Fanconi Anemia in siblings with bi-allelic BRIP1 mutations.
Date: Friday, March 24, 2017: 10:30 a.m.—12:00 p.m. MST.
Location: Poster 378.
Presenter: Jamie Willmott.

Title: Prevalence and characterization of triplications in genes associated with hereditary cancers.
Date: Friday, March 24, 2017: 10:30 a.m.—12:00 p.m. MST.
Location: Poster 148.
Presenter: Heather LaBreche.

Title: Apparent gene conversion event detected in CHEK2 using next generation sequencing analysis.
Date: Friday, March 24, 2017: 10:30 a.m.—12:00 p.m. MST.
Location: Poster 156.
Presenter: Shujuan Pan.